Colleagues,
Interesting article describing a Seattle based hybrid fund - cross between an Angel network and Early Stage VC. Appears they are deftly targeting an underserved niche.
In challenging times, may be a strategy with some long term merit. LP risk is limited. Ideal, perhaps, for med tech start-ups emerging from labs in regional clusters where Risk Capital is relatively scarce, but Medical Technology is excellent, i.e., National Capital Area (MD/DC/VA), Ohio (Cleveland & NE Ohio), Indiana (Indianapolis), Wisconsin (Madison), Arizona (Tucson/Phoenix), Penn (State College/Pitt/Phil), Utah (Salt Lake), New York (Rochester), Ect..
See article at:
http://www.xconomy.com/boston/2008/10/16/founders-co-op-gets-warm-reception-wants-startups-that-will-survive-cold-recession/#comment-32311
CC
CEO, VC & Angels Group, https://medtechiq.ning.com/group/medicalangelsvcs
You need to be a member of MedTech I.Q. to add comments!
Join MedTech I.Q.